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Abstract
Background The aim of the present study was to investigate the effects of Lactobacillus acidophilus D2/CSL 
(CECT 4529) probiotic strain on nutritional status and faecal and microbiological parameters in a group of 
purebred boxers.
Methods Forty healthy adult boxer dogs were randomly assigned to a treated (LACTO) group receiving a 
commercial diet supplemented with L acidophilus D2/CSL (CECT 4529) to a final concentration of 5.0 x 109 
colony- forming unit/kg of food, and a control (CTR) group receiving the same diet but without the probiotic 
(placebo). Nutritional status (body weight, skinfold thickness, body condition score) and faecal quality 
parameters were analysed.
Results No differences in body weight and skin thickness were found during the whole experimental period. 
Dogs in the LACTO group showed a significantly higher body condition score than those in the CTR group 
(4.86±0.55 v 4.65±0.65), and no significant differences were recorded in body weight and skinfold thickness. 
The LACTO group showed a significantly lower faecal moisture (in per cent) compared with the CTR group 
(0.67±0.007 v 0.69±0.007). Faecal hardness (in kg) was higher in the LACTO group than in the CTR group 
(0.86±0.047 v 0.70±0.051), and faecal score also improved in the LACTO group (3.78±0.95 v 4.25±0.91). A 
significant difference in total Escherichia coli counts as well as in lactobacilli counts between the CTR and LACTO 
groups was only detected at 28 days.
Conclusion Supplementation of L acidophilus D2/CSL (CECT 4529) significantly improved the nutritional status 
and faecal parameters of dogs.
Introduction
The gastrointestinal (GI) microbiota of animals is 
a complex ecosystem composed of a consortium of 
bacteria, archaea, eukarya (especially fungi) and 
viruses. It has a strong influence on maintenance 
of normal gut function and the general health of 
hosts.1 2 One of the main roles of a mature and balanced 
GI microbiota is colonisation resistance, also defined as 
competitive exclusion or barrier effect.3 Specifically, the 
GI microbiota works together with the host’s other non- 
specific defences and with the gut- associated immune 
system in order to resist the invasion of dangerous 
organisms.4 However, the balance among the microbial 
GI communities within a host, or eubiosis, changes over 
time due to physiological and/or environmental causes, 
including ageing, changes in feed formula, dietary 
restrictions, stress and immunodepression, infections, 
and antibiotic treatments.5–7 Some alterations in the GI 
microbiota, or dysbiosis, can affect animal wellbeing by 
promoting obesity or increasing faecal water content. 
The reduction of beneficial bacteria and the increase 
of proinflammatory/pathogenic bacteria in the gut 
are consistently associated with the development of 
adipose tissue, systemic inflammation and metabolic 
comorbidities in both people and mice.8–11
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In dogs, it has been shown that administration of 
some diets differentiated in supplementation with 
chicory (inulin), non- digestible oligosaccharide and 
glucose, or in the protein content can modify the 
faecal counts of Clostridium perfringens and reduce 
Bifidobacterium species. Such dysbiosis can induce 
a reduction in stool consistency.12 13 In addition, the 
effects of severe dysbiosis on gut physiology could be 
severely health- threatening, potentially causing acute 
and chronic GI inflammation, atopic diseases and 
intestinal cancer.5 6 14 As an example, human and canine 
inflammatory bowel disease has been associated with 
an increase in Proteobacteria (eg, Escherichia coli) and 
a decrease in Firmicutes in the intestine.15 16
At present, there is an increasing interest in finding 
a way to naturally modify the GI microbiota, with 
positive effects on health and welfare as a result.17 
Feeding animals with probiotic lactobacilli (LB) could 
be one of the possible ways. Lactobacillus species, such 
as L acidophilus, can be identified in the GI tract of 
healthy dogs.18 Similar to people and other mammals, 
including rodents and cats, it could be supposed that, 
even considering interindividual and intraindividual 
variations, LB becomes established in the GI tract of 
dogs soon after birth and reaches compositional stability 
with growth,19 and its principal activity is inhibition of 
undesirable microorganism proliferation.20 21
However, the relative abundance of intestinal LB 
varies over time. Dysbiosis, as a result of an unbalance 
between lactic acid bacteria and pathogenic bacteria 
(eg, C perfringens and E coli), is commonly observed 
in companion animals. It leads to excretion of softer 
or watery stools, as reported in dogs and cats by 
Weese et al22 and Marks et al.23 Live LB, as recently 
written by the Food and Agriculture Organization,24 
‘when administered in an adequate amount, confer a 
beneficial health effect to the host’ and can be defined 
as probiotics. Modes of action of probiotic LB strains 
include competitive exclusion towards undesirable 
bacteria, alteration of microbial and host metabolism, 
and immunity stimulation.25 In human medicine, 
probiotic LB has been largely used to manage a 
number of disorders related to GI dysbiosis, such as 
antibiotic- associated diarrhoea, intestinal infections 
and inflammations.26 27 Probiotic LB is able to suppress 
mucosal inflammation and restore cytokine balance 
towards an anti- inflammatory state.28 It is interesting 
to note that, along with its subtherapeutic benefits, 
the antiobesity effects of probiotic LB have also been 
reported in the scientific literature about mice.11 29
In general, the microbial strain, dose (colony- 
forming unit (cfu)/day) and duration of treatment 
are among the critical factors influencing the efficacy 
of probiotics.30 Indeed, probiotic effects are strain- 
specific and the outcomes vary depending on the 
targeted animal species.24 To the authors’ knowledge, 
no experimental trials on dogs have been performed 
yet. In this study, the authors investigated the change 
in selected parameters they considered as potential 
indicators of animal welfare especially in terms of ‘gut 
health’, following the administration of L acidophilus 
D2/CSL probiotic to dogs. Specifically, the authors 
evaluated the nutritional status, faecal consistence 
and moisture content of stool samples, as well as some 
faecal microbiological parameters (faecal total coliform 
(coli) and LB count) related to intestinal dysbiosis.
Aim
The aim of the present study was to investigate the effects 
of L acidophilus D2/CSL (CECT 4529) probiotic strain 
on nutritional status and faecal and microbiological 
parameters in a group of purebred boxer dogs.
Materials and methods
Experimental design
The experimental design comprised two consecutive 
stages: a seven- day adaptation period, followed by a 
35- day data collection experimental period.
Animals
Forty healthy adult dogs (breed: boxer; male to female 
sex ratio (M:F) of 1:5; age >1 year; two dogs per box, M+F, 
F+F; box measurement: indoor+outdoor=6 m2+6 m2) 
were randomly assigned to a control group (CTR: 
n=20, weight 23.1±0.7) fed a balanced commercial 
diet for 35 days and a treated group (LACTO: n=20, 
weight 23.4±0.6) receiving the same commercial diet 
supplemented with L acidophilus D2/CSL (CECT 4529). 
A daily health check- up was conducted by the kennel vet. 
Before starting the study (two weeks), an antiparasitic 
treatment was carried out using commercial molecule 
drugs with no antibacterial effect (Frontline Combo, 
Boehringer Ingelheim, spot on, one administration per 
dog; Drontal Plus Flavour, Bayer Animal Health, tablet, 
one administration per dog). A one- week acclimation 
period was applied before the data collection period.
Diets and supplementation
Dogs received a commercial extruded dry pet food 
with the amount calculated according to the energy 
maintenance requirements of adult dogs (130 kcal x 
BW0.75 kg; European Pet Food Federation (FEDIAF) 
2017 and National Research Council (NRC) guidelines, 
350–370 g/day/dog). Feed ingredients and chemical 
composition are reported in table 1. The LACTO group 
received food supplemented with L acidophilus CECT 
4529 to a final concentration of 5.0 x 109 cfu/kg of 
food. The dogs of the CTR group received the same diet 
with the same supplementation of maltodextrin but 
without L acidophilus (10 g; placebo). Probiotic dose 
was verified by analysing every week five samples of 
LACTO food (European Standard No EN 15787:2009: 
E- Animal feeding stuffs- Isolation and enumeration 
of Lactobacillus species). Feed intake was recorded. 
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Table 1 Ingredients and chemical composition of the diet fed during the 
trial
Ingredients: chicken (chicken 26%, total poultry 39%): maize, poultry meat meal, 
maize gluten meal, animal fat, digest, vegetable oil, minerals, beet pulp, flaxseed, 
rice, vitamins and trace elements. With natural preservatives and antioxidants.
Analytical constituents
 Dry matter
Protein 23.80%
Fat 16.40%
Carbohydrate (NFE) 52.80%
Fibre (crude) 1.80%
Calcium 0.81%
Phosphorus 0.70%
Sodium 0.31%
Potassium 0.75%
Magnesium 0.09%
Omega-3 fatty acids 0.51%
Omega-6 fatty acids 3.70%
Vitamin A 7180 iu/kg
Vitamin D 797 iu/kg
Vitamin E 656 mg/kg
Vitamin C 98 mg/kg
Beta- carotene 1.6 mg/kg
ME 3750 kcal/kg
ME, metabolisable energy; NFE, nitrogen- free extract.
Standard animal husbandry procedures were carried 
out by the same operator in both the experimental 
groups according to daily routine protocols for the 
entire duration of the experimental period.
Data collection and analysis
Nutritional status was monitored according to the 
Nutritional Assessment Guidelines for Dogs and Cats.31 
Body weight (BW in kg) (measured using a large pet 
scale, four- sensor, maximum of 100 kg, d=100 g; 
Momert, Dunaújváros, Hungary) and body condition 
score (BCS) (n=1–9; measured by the same trained 
operator) were monitored on days 0, 7, 14, 21, 28 and 
35.
Skinfold thickness was measured using a calliper at 
the level of the fourth cervical vertebra (neck) and of the 
seventh/eighth rib on the right side (thorax) on days 7 
and 35.32
Faecal score (FS), faecal moisture (FM) and faecal 
hardness (FH) and the count and identification of coli 
and LB were considered as indicators of the dog’s gut 
health status.
Faecal analyses were performed on 0, 7, 14, 21, 
28 and 35 days of the probiotic administration. Single 
samples of fresh faeces per dog were collected after 
deposition (08.30–09.00, 30–60 minutes after feed 
administration). All samples were kept in a numbered 
(box/dog- coded number) plastic bag, then stored 
at 4°C until their transport to the laboratory. Faeces 
analysis was carried out following a blinded sample 
identification protocol.
Faecal firmness was evaluated as FS using a 7- point 
score,33–35 and as FM (in per cent). To measure FM, 
5–10 g stool sample was weighed and dried in an oven 
at a temperature of 105°C–110°C for 20–24 hours 
and then weighed using Sartorius CP224S (maximum 
of 200 g, d=0.1 mg; Sartorius, Bohemia, New York, 
USA). Furthermore, at 0, 7, 21 and 35 days, FH (in 
kg) was measured on fresh faeces (50 g) with a fruit 
penetrometer 53220 FTA (GUSS Manufacturing, South 
Africa), replacing the supplied punch (cone) with a 4 x 
4 cm plate. This modification was necessary to facilitate 
assessment of faecal consistency because the faeces are 
softer than the fruits pulp; three repetitions per sample 
were performed.
Microbiological analysis
Faeces were collected at 7 and 28 days following the 
described procedure and were analysed from each dog. 
An aliquot of fresh faeces (1 g) was diluted in sterile 
saline solution with a ratio of 1:10. Diluted faeces were 
vortexed for two minutes to obtain a homogeneous 
suspension and were streaked on different culture 
media for total bacterial count and for bacterial 
identification. For E coli and total coli, eosin methylene 
blue agar (Oxoid, Italy) was used. After an incubation 
time (24 hours) at 37°C, E coli colonies have grown 
with a green metallic reflex, while coli have grown with 
blue or red or uncoloured colonies. De Man, Rogosa 
and Sharpe agar (Oxoid) was used for the growth and 
enumeration of Lactobacillus species, incubating plates 
under anaerobic conditions at 37°C for 48 hours.
The data obtained were analysed using MIXED, GLM 
and NPAR1WAY procedures (SAS V.9.4), with P≤0.05 
considered statistically significant.
Results and discussion
All dogs were healthy throughout the study. During the 
study no changes in feed consumption were recorded 
(350–370 g/day/dog; waste=0 g throughout the 
experimental period).
No differences in BW (CTR=23.5±0.7 kg v 
LACTO=23.9±0.6 kg) and skin thickness (neck, 
CTR=4.97±0.34 mm v LACTO=5.37±0.33 mm; thorax, 
CTR=4.80±0.38 mm v LACTO=4.40±0.37 mm) were 
found in dogs receiving treatment and control diets 
during the whole experimental period. The average skin 
thickness in dogs varies from 0.5 to 5 mm depending on 
the breed,22 and these results are consistent throughout 
the experimental period in the two experimental 
groups characterised by standardisation of breed, sex 
ratio, feed, environment and management. Skinfold 
measurements are well- known procedures in 
nutritional status evaluation and obesity quantification 
and monitoring.36
Dogs in the LACTO group showed a significantly 
higher BCS than those in the CTR group throughout 
the experimental period (4.65±0.65 v 4.86±0.55) 
and at 7 and 14 days (4.75±0.45 v 5±0.00) (table  2). 
These results suggest that the supplementation of L 
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Table 3 Effect of Lactobacillus acidophilus D2/CSL addition to diet on dog 
performance: least square means (±se) relative to CTR and LACTO groups for 
FM and FH
Groups
P valueCTR LACTO
FM (%)
  Overall period 0.69±0.007 0.67±0.007 0.0198
  0 day 0.66±0.013 0.68±0.013 0.5169
  7 days 0.71±0.016 0.72±0.012 0.3354
  14 days 0.66±0.012 0.63±0.012 0.0756
  21 days 0.70±0.013 0.65±0.012 0.0010
  28 days 0.73±0.013 0.68±0.012 0.0040
  35 days 0.69±0.013 0.68±0.012 0.7295
FH (kg)*
  Overall period 0.70±0.051 0.86±0.047 0.0035
  0 day 0.62±0.066 0.69±0.057 0.2958
  7 days 0.49±0.066 0.57±0.057 0.2741
  21 days 0.88±0.066 1.11±0.057 0.0024
  35 days 0.82±0.066 1.09±0.057 0.0002
*Pressure related to a 4 x 4 cm plate.
CTR, control group; FH, faecal hardness; FM, faecal moisture; LACTO, treated group.
Table 4 Effect of Lactobacillus acidophilus D2/CSL addition to diet on 
faecal score: descriptive statistics and results from Kruskal- Wallis test
Period Group Mean sd Median
Percentile (25th, 
75th)
Overall period CTR 4.25 0.91 4a 4, 5
  LACTO 3.78 0.95 4b 3, 5
0 day CTR 4.88 0.34 5 5, 5
  LACTO 4.83 0.64 5 4, 5
7 days CTR 4.94 0.25 5 5, 5
  LACTO 4.83 0.48 5 5, 5
14 days CTR 3.93 1.62 4 3, 5
  LACTO 3.11 0.88 3 2, 4
21 days CTR 3.86 0.53 4a 4, 4
  LACTO 3.25 0.44 3b 3, 3.5
28 days CTR 3.86 0.53 4a 4, 4
  LACTO 3.25 0.44 3b 3, 3.5
35 days CTR 3.86 0.53 4a 4, 4
  LACTO 3.25 0.44 3b 3, 3.5
Within each period, medians with different superscript letters differ (P<0.05).
CTR, control group; LACTO, treated group.
Table 2 Effect of Lactobacillus acidophilus D2/CSL addition to diet on 
body condition score: descriptive statistics and results from Kruskal- Wallis 
test
Period Group Mean sd Median
Percentile 
(25th, 75th)
Overall period CTR 4.65 0.65 5a 4, 5
  LACTO 4.86 0.55 5b 5, 5
0 day CTR 4.88 0.34 5 5, 5
  LACTO 4.96 0.20 5 5, 5
7 days CTR 4.75 0.45 5a 4.5, 5
  LACTO 5 0 5b 5, 5
14 days CTR 4.75 0.45 5a 4.5, 5
  LACTO 5 0 5b 5, 5
21 days CTR 4.63 0.62 5 4, 5
  LACTO 4.71 0.69 5 4.5, 5
28 days CTR 4.44 0.89 5 4, 5
  LACTO 4.75 0.79 5 4, 5
35 days CTR 4.44 0.89 5 4, 5
  LACTO 4.75 0.79 5 4, 5
Within each period, medians with different superscript letters differ (P<0.05).
CTR, control group; LACTO, treated group.
acidophilus CECT 4529 could improve the nutritional 
status of dogs. BCS is a direct method for evaluating 
nutritional status, with scores ranging from 1 to 9 and 
with the ideal body condition being a score of 4 or 5 
depending on the breed.37 In the ideal range, the body 
fat ratio can be assumed to range between 15 and 25 
per cent, and in these scores (4–5) the ideal BW can be 
assumed. Jeusette et al38 estimated a 19±8 per cent fat 
mass in dogs with a BCS score of 5.
Some authors even observed an antiobesity effect of 
probiotic LB. For example, a strain of L gasseri (LG2055) 
significantly prevented BW gain, fat accumulation and 
proinflammatory gene expression in the adipose tissue 
of obese mice.39 In dogs, Park et al40 reported how the 
gut microbiome, through vagal afferent neurons, is 
able to regulate neuronal signalling to the brain. They 
described how obesity could be linked to microbiota 
composition and serotonin concentrations in the CNS.
Wang et al11 demonstrated the utility of L paracasei 
CNCM I-4270, L rhamnosus I-3690 and Bifidobacterium 
animalis lactis I-2494 strains to individually attenuate 
high- fat diet- induced obesity, inflammation and 
metabolic syndrome in mice. Although a definitive 
explanation of the antiobesity effect of some probiotic 
strains does not exist, it is known that the intestinal 
microbiota is involved in the regulation of fat storage in 
dogs.40 41 Microbiota of obese mice leads to an increased 
concentration of fermentation end products butyrate 
and acetate, so it is more efficient at extracting energy 
from a given diet than the microbiota of lean animals.8
The results of this study are consistent with the 
observations of different authors,9 42 43 and suggest 
that administration of probiotic may favour a different 
equilibrium in the intestinal microbiota and is less 
effective in fermenting the indigestible residues of the 
diet, therefore providing better control of weight in 
adult boxer dogs.
Considering faecal parameters, a lower FM in the 
LACTO group was recorded compared with the CTR 
group (0.69±0.007 v 0.67±0.007, P≤0.05) throughout 
the experimental period. Similar results were pointed 
out in FH and FS. Throughout the experimental period, 
FH was also higher in the LACTO group (table  3) 
compared with the CTR group (0.86±0.047 kg v 
0.70±0.051 kg, P≤0.05).
Significant differences in FS were found in the 
five- week period (table  4): lower scores were detected 
in the LACTO group compared with the CTR group 
(3.78±0.95 v 4.25±0.91). All the results concerning 
faecal parameters (FS, FM, FH) indicate an improvement 
in faecal consistency in the LACTO group.
A significant difference in total coli log counts was 
only detected at 28 days between the CTR (4.92) and 
LACTO (5.59) groups (table  5). LB was detected in 
stools at 28 days, and counts of these bacteria were 
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Table 5 Effect of Lactobacillus acidophilus D2/CSL addition to diet on dog 
performance: least square means (±se) relative to faecal total coliform (coli) 
and lactobacilli (LB) counts
Groups
P valueCTR LACTO
Coli (log10(N))
Overall period 4.54±0.24 4.71±0.15 0.3053
7 days 4.16±0.17 3.84±0.17 0.1227
28 days 4.92±0.16 5.59±0.17 0.0023
LB (log10(N))
28 days 4.50±0.22 5.64±0.26 0.0005
CTR, control group; LACTO, treated group.
significantly (P≤0.01) higher in the LACTO group 
(5.64±0.26) than in the CTR group (4.50±0.22).
Dysbiosis, or the unbalance between lactic acid 
bacteria and putrefactive and/or pathogenic ones, is 
commonly observed in people and animals. Bacterial 
enteropathogens (C difficile, C perfringens, Salmonella 
ser, Campylobacter jejuni and pathogenic E coli) have 
been frequently isolated from the faeces of clinically 
healthy dogs and cats.23 Release of toxic bacterial 
metabolites is quantitatively dependent on the type of 
fermentations that occur in the bowel,5 and putrefactive 
fermentation profiles can have detrimental effects on 
the intestinal mucosa and faecal consistency. Ammonia 
and valeric acid concentrations were higher in soft 
stools, suggesting a higher level of protein fermentation 
in softer faeces.44
Reported results are in accordance with those written 
by different researchers who described the ability 
of L acidophilus to inhibit the growth of potentially 
pathogenic bacteria45 and to improve immune function 
and intestinal health in dogs.46 Some of the tested 
parameters have also been used by Pascher et al in 
200847 to evaluate feed tolerance in dogs with non- 
specific dietary sensitivity. In agreement with the results 
of the present study, they found that faecal consistency 
and faecal dry matter were improved by inclusion of L 
acidophilus in dogs’ diet.
The nutritional status and the gut status parameters 
that the authors have evaluated in healthy dogs were 
improved by addition of L acidophilus D2/CSL (CECT 
4529) to diet. Moreover, considering the findings of 
Herstad et al (2010),48 a further potential use in case of 
self- limiting diarrhoea could be suggested.
Conclusions
The inclusion of L acidophilus D2/CSL (CECT 4529) at 
the recommended dosage of (at least) 5.0 x 109 cfu/
kg of dry food showed a significant positive effect on 
faecal consistency (FS, FH and FM) in adult dogs. In 
addition, the count of faecal LB was higher in dogs fed 
with diet supplemented with L acidophilus D2/CSL. A 
significant positive effect on the nutritional status of 
dogs was highlighted, given the ideal BCS of around 5 
reported in the results. Further studies could be carried 
out focusing on the antiobesity effects of L acidophilus 
strains. Considering faecal quality, the importance of 
faecal dryness in dogs management in indoor (soiling 
pet animals) situation and in urban areas where faeces 
consistency could favour collection and elimination 
procedures is helpful.49
In conclusion, the supplementation of L acidophilus 
D2/CSL (CECT 4529) significantly improved the welfare 
of boxer dogs, improving their gut health and in turn 
the quality of their stools. Furthermore, the nutritional 
status of dogs was positively influenced.
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